Quantcast
Channel: Videos – Cancer Genetics Inc.
Viewing all articles
Browse latest Browse all 19

Cancer Genetics offers the FDA-approved DAKO PD-L1 IHC 22C3 pharmDx companion diagnostic test for KEYTRUDA®

$
0
0

The FDA approved PD-L1 (IHC) 22C3 pharmDx companion diagnostic test for  KEYTRUDA® (pembrolizumab)​ is now available at CGI to assess PD-L1 expression in Non-Small Cell Lung Cancer


Viewing all articles
Browse latest Browse all 19

Latest Images

Trending Articles





Latest Images